Donna Behring is a seasoned leader in the clinical research industry, currently serving as the President and CEO of The Clinical Research Group, Inc., which she established in 2000. Under her visionary leadership, the organization has become a prominent Site Management Organization (SMO) specializing in...
Donna Behring is a seasoned leader in the clinical research industry, currently serving as the President and CEO of The Clinical Research Group, Inc., which she established in 2000. Under her visionary leadership, the organization has become a prominent Site Management Organization (SMO) specializing in Phase II to Phase IV clinical trials across a diverse range of therapeutic areas, including oncology and neurology. With a robust operational footprint spanning Texas, Florida, North Carolina, New Jersey, Puerto Rico, and the Virgin Islands, Donna has successfully positioned The Clinical Research Group as a trusted partner for private practice physicians seeking to navigate the complexities of clinical trials.
Donna's expertise in pharmaceutics and electronic data capture (EDC) is complemented by her strong background in regulatory submissions and ICH-GCP compliance, ensuring that all trials adhere to the highest industry standards. Her strategic planning and process improvement skills have been instrumental in optimizing clinical monitoring practices, enhancing data integrity, and driving successful outcomes for sponsors and investigators alike.
In addition to her operational acumen, Donna is a dynamic public speaker, frequently sharing insights on the evolving landscape of clinical research and the importance of collaboration among stakeholders. Her commitment to fostering innovation within the pharmaceutical industry and her dedication to advancing patient care through rigorous clinical research underscore her role as a key influencer in the field. With a Master’s degree in Kinesiology from Texas Woman's University, she combines academic knowledge with practical experience, making her a respected authority in the clinical research community.